LSHC Archives

Research & Development

The Game-Changing Influence of Key Opinion Leaders in Healthcare

Introduction Key Opinion Leaders (KOLs) are crucial in shaping opinions and influencing decisions in the healthcare and pharma industries. In today’s

Innovation Intelligence & IP Solutions

Unlocking the Future of Healthcare: The Advantages of Digital Health for Pharmaceutical Companies

Healthcare is rapidly transforming with digital health, offering benefits like improved patient outcomes, greater efficiency, and cost reduction. However, realising these advantages requires close collaboration between healthcare providers, policymakers, and technology companies. By working together, a cohesive ecosystem can be created that uses technology to deliver patient-centric care.

Research & Development

Cell and Gene Therapy – Current Scenario and Outlook

The Cell and Gene Therapy (CGT) Area has gained traction in recent years. A majority of big pharma has CGT assets in their pipeline. While it has a strong pipeline, the area witnessed a continued flow of investment. In our latest industry report on Cell and Gene Therapy Sector Performance and Outlook, we discuss how and why we believe that the CGT area has a lot to offer and except to see continued growth.

Corporate and Investment Banking

Products that Create Outcomes.

Results Powered by Subject Matter Experts.

Industry Specific Expert-Driven Solutions.

Strengthen Your Analytics Knowledge.

LSHC